已收盤 09-12 16:00:00 美东时间
-1.540
-1.90%
(来源:药剂Talks) 近期,FDA发布了《肿瘤临床试验中总生存期评估方法指南草案》,首次系统明确总生存期(OS)在随机对照试验中的核心地位及其具体操作规范...
09-13 09:01
AstraZeneca (AZN) and Eli Lilly (NYSE:LLY) have become the latest leading drugmakers to reconsider their investment options in the U.K. after Merck (MRK) canceled plans for a £1B research center in Lo...
09-13 02:55
Pharmaceutical companies are pulling investment from the UK as NHS drug spending falls and pricing disputes worsen.
09-13 02:21
AstraZeneca (NASDAQ:AZN) has become the latest leading drugmaker to reconsider its investments in Britain, as the Anglo-Swedish pharma giant has paused plans for a £200M (~$271M) investment in its Cam...
09-13 01:59
- Reuters
09-13 00:34
https://www.washingtonpost.com/health/2025/09/12/covid-vaccine-child-death-cdc/
09-12 23:45
文|胡香赟 编辑|海若镜 特朗普政府盯上了正在“批量”BD出海的中国创新药。 9月10日,外媒报道称,特朗普政府正在筹备一项新的针对中国医药行业的行政令草案,主...
09-12 21:40
目前来看,且不论特朗普政府推出的草案合法性可能受到司法系统审查而难以落地,从上述数据也不难看出,生物科技公司正在重塑全球生物制药的创新格局,低成本、高效率的创新资产已成为MNC对抗专利悬崖的重要解决方案。
09-12 16:15